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Effects of Disinfectants in Renal Dialysis
Patients
by Elias Klein*
Patients receiving hemodialysis therapy risk exposure to 'both disinfectants and sterilants. Dialysis
equipment isdisinfected periodicallywith strongsolutions ofhypochloriteorformaldehyde. Morerecently,
reuse ofdialyzers has introduced the use ofadditional sterilants, such as hydrogen peroxide and peracetic
acid. The use of these sterilants is recognized by the center staffs and the home patient as a potential
risk, and residue tests are carried out forthe presence ofthese sterilants attheppm level. Gross hemolysis
resulting from accidental hypochlorite infusion has led to cardiac arrest, probably as a result of hyper-
kalemia. Formaldehyde is commonly used in 4% solutions tosterilize the fluidpaths ofdialysis controllers
andto sterilize dialyzers before reuse. It can reactwithred cell antigenic surfaces leadingtothe formation
of anti-N antibodies. Such reactions probably do not occur with hypochlorite or chloramines.
The major exposure risk is the low concentration of disinfectant found in municipal water used to
prepare 450 L dialysate weekly. With thrice-weekly treatment schedules, the quality requirements for
water used to make this solution must be met rigorously. Standards for water used in the preparation of
dialysate haverecentlybeenproposedbutnotallpatients aretreatedwithdialysatemeetingsuchstandards.
The introduction ofsterilants via tap water is insidious and has led to more pervasive consequences. Both
chlorine and chloramines, at concentrations found in potable water, are strong oxidants that cause ex-
tensive protein denaturation and hemolysis. Oxidation of the Fe2" in hemoglobin to Fe3" forms methe-
moglobin, which is incapable ofcarrying either02 orCO2. Chloramine can form notonly methemoglobin,
but can also denature proteins within the red cell, thus forming aggregates (Heinz bodies). Chloramines
also inhibit hexose monophosphate shunt activity, a mechanism that makes the red cell even more sus-
ceptible to oxidant damage.
These risks can only be minimized through close cooperation between the clinical staffs and the water
carrier's technical personnel.
Introduction
In mid-1985 there were 78,500 patients in the United
States suffering from end stage renal disease (ESRD)
requiring supportive dialysis therapy. Ofthis number,
66,600 were treated by hemodialysis, 62,500 were
treated in centralized facilities, and 4,100 were treated
at home. Hemodialysis treatment typically consists of
a4-hrdialysis, duringwhichtime anelectrolyte solution
(dialysate) flows countercurrent to the patient's blood,
separated from the latter only by approximately one
square meterofan8to 11 ,umthickcellulose membrane.
A schematic ofthe flow path is shown in Figure 1.
During the course of the treatment, the patient's
blood is equilibrated with approximately 120 L of di-
alysate, prepared by metering a concentrated salt so-
lution into tap water purified for this purpose (water
for dialysate). The patient, therefore, is exposed to 70
to 80 times the normal daily waterintake (1.5-2 L/day).
Moreover, all ofthe low molecular weight constituents
ofpotable water-many ofwhich cannot cross the gas-
trointestinal barrier-can be transferred into the cir-
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FIGURE 1. Flow diagram of typical dialysate preparation system.
culation ofthe hemodialysis patient. Many ofthese sol-
utes may not be considered toxic as they are not
normally absorbed. Because ofthe possibility of direct
diffusion into the patient's serum, suchpotentially toxic
substances must be removed from the water supply
before the dialysate is formulated. These substances
include the flocculating agents used to settle turbidity,
transition elements, and all sterilants or disinfectants
used to control biological burdens.
The determination of permissible toxic burdens for
these patients is an on-going effort, made more difficult
by the complications ofthe underlying diseases present
intheESRDpopulation. Currently, there arestandards
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Table 1. Hemodialysis water quality-chemical contaminant
levels.
Contaminant Suggested maximum level, mg/L
Calcium 2 (0.1 mEq/L)
Magnesium 4 (0.3 mEq/L)
Sodiuma 70 (3 mEq/L)
Potassium 8 (0.2 mEq/L)
Fluoride 0.2
Chlorine 0.5
Chloramines 0.1
Nitrate (N) 2
Sulfate 100
Copper, barium, zinc each 0.1
Aluminum 0.01
Arsenic, lead, silver each 0.005
Cadmium 0.001
Chromium 0.014
Selenium 0.09
Mercury 0.0002
'230 mg/L (10 mEq/L) where sodium concentration ofthe concen-
trate has been reduced to compensate for the excess sodium in the
water, as long as conductivity of the water is being continuously
monitored.
for hemodialysis systems, which were prepared in 1981
by committees ofthe Association for the Advancement
ofMedical Instrumentation (AAMI) (1). The section ap-
plicable to the preparation of water for dialysate is
shown in Table 1. Note that the preponderance of con-
cern is with inorganics; only chlorine and chloramine
are listed in the category of sterilants or disinfectants.
Disinfectants and Sterilants
The home hemodialysis patient and dialysis center
support staff must deal with both sterilants and disin-
fectants toreduce bacterial burdensinthe fluidpathway
of their respective dialysis equipment. Most patients
are served by municipal water carriers who provide
bacterial control through either chlorine or chloramine
in the water reaching the dialysis facility, whether in
the home or centrally located. These oxidants must be
removed from the water used for dialysis for reasons
to be cited later. Between the point of removal of the
chlorine compound(s) and the actual dialysis step, the
fluid path of the machinery can, and does, harbor bac-
terial cultures. These bacterial burdens may be aggra-
vated by the presence ofsand filters, carbon adsorption
beds, and other water-treating equipment interposed
between the supply line and the dialysate controllers.
To manage the inevitable bacterial contamination, di-
alysis equipment manufacturers recommend daily dis-
infection and periodic sterilization.
The most commonly used disinfectant is a basic so-
lution of sodium hypochlorite. A 0.25% solution is cir-
culated through the fluid pathways, followed immedi-
atedly by extensive rinsing with water fordialysis. The
washing is continued until the effluent concentration is
reduced below 0.5 ppm active chlorine. Hemodialysis
controllers are also sterilized, typically on a biweekly
basis, using 3.75% formaldehyde exposure for at least
16 hr. The entire fluid pathway must be rinsed after
sterilization until the effluent concentration of formal-
dehyde is less than 5.0 ppm.
In many hemodialysis facilities, it is now common
practice to submit dialyzers to a reuse procedure in
which the adhering blood products are washed out of
the dialyzer and the cleansed dialyzer is sterilized by
storage in one ofseveral sterilants untiljustbefore use.
The most commonly used sterilant is 4% formaldehyde
solution; a mixture ofperacetic acid and hydrogen per-
oxide is also used, but experience with this solution is
less extensive. When formaldehyde is used as the di-
alyzer sterilant, an intermediate wash step containing
sodium hypochlorite may be used to solubilize adhering
protein through oxidation. The peroxide solutions do
not require additional oxidative denaturation of adher-
ing protein.
All these sterilants must be removed not only from
the dialyzer fluid pathways, but also from the plastic
materials into which they may have diffused. Other-
wise, traces of sterilant may be dialyzed into the pa-
tient's blood stream with the same ease as metabolic
products dialyzed out of the blood stream.
Systemic Effects of Sterilants and
Disinfectants
Sodium Hypochlorite
An accidental systemic exposure ofa patient to high
concentrations ofsodium hypochlorite was reported by
Hoy (2). In the reported accident, the disinfection pro-
cedure ofthe dialysate controller was begun before the
patient had completed treatment. An estimated dose of
30 mL of 3% hypochlorite was transferred to the pa-
tient, based on changes in serum electrolyte levels. Im-
mediate hemolysis of the patient's blood resulted in a
doubling ofserum potassium concentration to 7.0 mEq/
L. The hyperkalemic levels resulted in cardiac arrest.
The rise in serum potassium is consistent with rapid
degradation of the erythrocyte, as reported by Baker
(3).
Monochloramine
A number of studies reporting the effects of chlora-
mine on blood components have been reported in the
last few years (4-8). Two major effects are observed.
The first is oxidation of hemoglobin to methemoglobin
in direct proportion tothe chloramine concentration (9).
Free chlorine, although an equally strong oxidant, does
not produce methemoglobin. A second consequence is
the denaturation ofhemoglobin to form insoluble Heinz
bodies (8) within the red cells. In addition to the oxi-
dative damage caused directly by chloramines, the ef-
fectismagnifiedbythe inhibition ofrepairmechanisms.
The hexose monophosphate shuntnormallyreduces nic-
otinamide adenine dinucleotide phosphate (NADPH),
which protects the red cells against oxidative damage.
Prior exposure ofred cells to chloramines inhibits this
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protective mechanism, subjectingthe cellstoevenmore
severe damage on subsequent exposure to chloramine.
Current awareness ofthe dangers of chloramine ex-
posure has been raised by standards introduced during
1985 by the California Department ofHealth (10). As a
consequence of chloramination of domestic water sup-
plies in southern California, a number of hemolytic
events were reported. Chloramination was stopped in
December 1984 until new regulations requiring dialysis
facilities to remove chloramine from their water sup-
plies could be promulgated. Since early 1985, all Cali-
fornia hemodialysis units operate under guidelines re-
quiring removal and testing for chloramine levels in
water used for dialysis. Unfortunately, many other
areas of the country, in the process of switching from
chlorine to chloramine to meet EPA trihalomethane
level guidelines, may not provide adequate warning to
permit hemodialysis centers to deal with the presence
of chloramines (Ronald L. Wathen, personal commu-
nication).
Formaldehyde
Formaldehyde at high concentrations poses a risk of
acutetoxicity. However, attracelevels, achronic effect
has been identified in the hemodialysis patient popula-
tion. Erythrocytes can be characterized in terms ofMN
phenotypes, analogous totheAB-O system. The normal
distribution of MM, NN, and MN phenotypes is ap-
proximately25%, 25%, and50%, respectively. Only25%
ofthe population would be expected to have anti-N an-
tibodies. However, patients exposed chronically to
trace levels of formaldehyde (by formalin sterilization
of their dialyzers to permit reuse) are reported to de-
velop anti-N-like antibodies, probably as a result ofre-
action with the dissolved form of formaldehyde, meth-
ylene glycol. The occurrence ofthis antibody has been
implicated in renalallograft failure (11). The anti-N-like
antibodies are formed following exposure to sodium hy-
pochlorite; no data are reported for the formation ofthe
antibodies in response to chloramine exposure.
Peroxides
The action ofstrong oxidants, such as hydrogen per-
oxide and peracetic acid, is expected to be immediate
and directed at protein oxidation. The literature does
not currently contain reports linking chronic exposure
to these oxidants with any systemic effects.
Conclusion
The use ofsterilants and disinfectants to reduce bac-
terial burdens in hemodialysis equipment is anecessary
consequence of unwanted infections of the fluid path-
ways. The biocidesintroduced bothbythewatercarrier
supplying the hemodialysis facility and those used to
maintain the equipment pose a serious risk to the pa-
tient. Chronic, subacute exposures have been shown to
damage a number of erythrocyte and plasma protein
functions. Damage includes shortened red cell life, de-
velopment ofautoimmune antibodies, and denaturation
of serum proteins.
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